 | | |
|
|
Home > News > Press Center > Press Release |
| |
Aetna Chairman And CEO John W. Rowe, M.D. To Testify Before Congress On Genetic Testing And Privacy Issues
HARTFORD, Conn., September 9, 2002 — Aetna (NYSE: ΑET) Chairman and CEO Dr. John W. Rowe is scheduled to testify in the U.S. House of Representatives on Thursday, September 12, 2002, at 10:00am. Dr. Rowe’s testimony before the House Judiciary Subcommittee on the Constitution will focus on issues related to the use and privacy of genetic information.
In a recent speech before the Inaugural Symposium on Genetic Privacy and Discrimination at the University of Rochester’s School of Medicine and Dentistry, Dr. Rowe called upon the medical profession, academics, policy makers and others to join Aetna in adopting guidelines for access to genetic counseling, genetic testing and the appropriate use of test results. A news release regarding that speech can be found at http://www.aetna.com/news/2002/pr_20020617.htm. A live audio feed will be available during the time of the meeting via the Judiciary Committee by accessing the hearing at www.house.gov/judiciary/schedule.htm. A complete transcript of Dr. Rowe’s statement will be available on the Aetna website (www.aetna.com) immediately following the hearing.
Aetna is one of the nation’s leading providers of health, dental, group life and long-term care benefits, serving 14.4 million health care members, 11.9 million dental members and 12.0 million group insurance customers, as of June 30, 2002. Information about Aetna is available at www.aetna.com.
|
|
